title: Association of the IGF1/pregnancy-associated plasma protein-A system and adipocytokine levels with the presence and the morphology of carotid plaques in type 2 diabetes mellitus patients with stable glycaemic control.
abstract: OBJECTIVE
  Pregnancy-associated plasma protein-A (PAPP-A) has been implicated in the atherosclerotic process through regulation of local expression of IGF1. In type 2 diabetes mellitus, glycaemic control has been involved in PAPP-A expression. We compared PAPP-A, IGF1, inflammatory markers and adiponectin concentrations in type 2 diabetic patients with and without carotid plaques and evaluated the relationship between these serum parameters and ultrasound carotid markers of atherosclerosis.
  
  
  METHODS
  We studied 125 consecutive type 2 diabetic patients. Clinical data, metabolic variables, hemostatic factors (plasma type-1 plasminogen activator inhibitor, fibrinogen), high-ultrasensitive C reactive protein (hsCRP), tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, adiponectin, IGF1 and PAPP-A were determined. Patients were classified into two groups according to the presence of carotid plaques on ultrasound. Carotid intima-media thickness (IMT) and morphology of carotid plaques were evaluated.
  
  
  RESULTS
  The mean age was 61.5+/-7.3 years and the mean glycated hemoglobin of 6.8+/-0.9%. A total of 60% presented carotid plaques. Both groups were homogeneous in anthropometric data, biochemical determinations and hemostatic factors. Adiponectin, hsCRP, TNF-alpha and IL-6 were similar in both groups. No differences were observed in serum PAPP-A (0.46 (0.22-0.86) vs 0.38 (0.18-0.66) mIU/l and in SDS IGF1 (-0.34+/-1.38 vs -0.67+/-1.35)) in patients with and without carotid plaques respectively. PAPP-A and IGF1 were not correlated with IMT.
  
  
  CONCLUSIONS
  Serum PAPP-A and IGF1 do not appear to be useful serum biomarkers for carotid atherosclerosis in type 2 diabetic patients with stable glycemic control, despite scientific evidence of their local role in atherosclerosis.
authors.affiliation: Endocrinology and Nutrition Service, Department of Internal Medicine, Universitat Autònoma de Barcelona, Germans Trias i Pujol University Hospital, 08916 Badalona, Barcelona, Spain. spellitero.germanstrias@gencat.cat
authors.forename: Silvia
authors.initials: S
authors.lastname: Pellitero
authors.forename: Jordi L
authors.initials: JL
authors.lastname: Reverter
authors.forename: María Luisa
authors.initials: ML
authors.lastname: Granada
authors.forename: Eduarda
authors.initials: E
authors.lastname: Pizarro
authors.forename: M Cruz
authors.initials: MC
authors.lastname: Pastor
authors.forename: Dolors
authors.initials: D
authors.lastname: Tàssies
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: Reverter
authors.forename: Isabel
authors.initials: I
authors.lastname: Salinas
authors.forename: Anna
authors.initials: A
authors.lastname: Sanmartí
mesh_terms: D054392:Adipokines / Q000097:blood*; D000368:Aged; D015415:Biomarkers / Q000097:blood; D002340:Carotid Artery Diseases / Q000097:blood / Q000378:metabolism* / Q000473:pathology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011266:Pregnancy-Associated Plasma Protein-A / Q000378:metabolism*
chemical_list: D054392:Adipokines; D015415:Biomarkers; D007334:Insulin-Like Growth Factor I; D011266:Pregnancy-Associated Plasma Protein-A